Dare Bioscience (DARE) Other Operating Expenses (2016 - 2024)
Dare Bioscience's (DARE) quarterly Other Operating Expenses came in at -$7674.0 in Q4 2024, down 130.7% YoY from $25000.0 in Q1 2024, and down 200.0% on a QoQ basis from $7674.0 in Q1 2024.
Dare Bioscience (DARE) Other Operating Expenses (2016 - 2024) Analysis & Trends
Dare Bioscience (DARE) has 9 years of Other Operating Expenses data on file, last reported at -$7674.0 in Q4 2024.
- Quarterly Other Operating Expenses fell 130.7% year-over-year to -$7674.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$7674.0 (down 123.49% YoY) and the FY2023 annual result came in at $100000.0, changed 0.0% from the prior year.
- Other Operating Expenses eased to -$7674.0 in Q4 2024, from $7674.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $25000.0 in Q3 2020 to a low of -$7674.0 in Q4 2024.
- A 5-year average of $21296.3 and a median of $25000.0 in 2020 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2021 — Other Operating Expenses surged 100.0% — and 2024, when it plunged 130.7%.
- Tracing DARE's Other Operating Expenses over 5 years: stood at $25000.0 in 2020, then changed by 0.0% to $25000.0 in 2021, then changed by 0.0% to $25000.0 in 2022, then changed by 0.0% to $25000.0 in 2023, then tumbled by 130.7% to -$7674.0 in 2024.
- The last three Other Operating Expenses figures came in at -$7674.0 (Q4 2024), $7674.0 (Q1 2024), and $25000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dare Bioscience | 12.36 Mn | -256,055.23 | -132,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -7,674.00 |
| Mar 31, 2024 | 7,674.00 |
| Dec 31, 2023 | 25,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 25,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | 25,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Sep 30, 2021 | 25,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 25,000.00 |
| Dec 31, 2020 | 25,000.00 |
| Sep 30, 2020 | 25,000.00 |
| Jun 30, 2020 | 20,833.00 |
| Mar 31, 2020 | 12,500.00 |
| Dec 31, 2019 | 125,001.00 |
| Sep 30, 2019 | 133,333.00 |